The Sudeep Pharma IPO is one of the key mainboard issues in November 2025, drawing strong interest from both retail and institutional investors. The company operates in the pharmaceutical excipients and specialty ingredients space, and the issue combines a fresh issue with a large offer for sale. With an active grey market and clear timelines for listing and allotment, investors are closely tracking the sudeep pharma ipo gmp, price band and listings date before taking a call.
About Sudeep Pharma
Sudeep Pharma manufactures mineral-based excipients and specialty ingredients used in pharmaceuticals, nutrition and food industries. Its product portfolio includes calcium salts and other functional ingredients that go into tablets, syrups and nutraceutical products. The company supplies to well-known Indian and global pharma formulators and plans to use the IPO proceeds to expand capacity and strengthen its balance sheet.
IPO Name
The offer is officially titled the Sudeep Pharma Limited IPO. It is a book-built mainboard IPO with a mix of fresh shares and an offer for sale by existing shareholders, aggregating to about ₹895 crore.
IPO Price Band and Lot Size
One of the most important details for any investor is the price band and minimum investment size. For the Sudeep Pharma IPO, these are clearly defined:
- Price Band: ₹563 to ₹593 per equity share
- Face Value: ₹1 per share
- Lot Size: 25 shares per lot
- Minimum Retail Investment: 1 lot (25 shares) ≈ ₹14,825 at the upper end of the band
- Issue Size: About ₹895 crore (₹95 crore fresh issue + ₹800 crore OFS)
This structure makes the sudeep pharma ipo accessible to retail investors while still sizeable enough for institutional participation.
IPO Open & Close Date
- IPO Open Date: 21 November 2025
- IPO Close Date: 25 November 2025
- Basis of Allotment (Tentative): 26 November 2025
- Refunds / Demat Credit (Tentative): 27 November 2025
The subscription window runs for three trading days, which is standard for a mainboard IPO.
Listings Date
The equity shares of Sudeep Pharma are proposed to be listed on both the NSE and BSE.
- Proposed Listings Date: 28 November 2025
- Exchanges: NSE and BSE
Listing performance will depend on overall market conditions, investor sentiment and how the IPO is subscribed across categories.
Grey Market Premium (GMP)
The sudeep pharma ipo gmp has been active in the unofficial market. Recent data from GMP trackers indicates a premium in the range of around ₹110–₹120 per share over the upper price band of ₹593. That implies an expected listing gain of roughly 18–20% if the sentiment holds.
However, GMP is unofficial and highly volatile. It should be treated only as a sentiment indicator, not as a guarantee of listing price.
Corporate Events & Use of Proceeds
The IPO structure and recent corporate actions include:
- Fresh Issue: Around ₹95 crore to be used for capacity expansion, working capital and general corporate purposes
- Offer for Sale (OFS): Around ₹800 crore by existing shareholders
- Anchor Book: The company has raised a substantial amount from marquee anchor investors ahead of the issue, signalling institutional confidence
These events show that the IPO is both a fund-raising exercise for future growth and a partial exit opportunity for current shareholders.
Dividend
Historically, Sudeep Pharma has focused more on reinvestment into the business rather than aggressive dividend payouts. Post listing, dividend decisions will depend on profit growth, cash flows and board policy. Investors looking at the IPO should treat it primarily as a growth play rather than a high-dividend story in the near term.
Bonus
There has been no bonus issue announced in conjunction with the IPO. Any future bonus shares will depend on the company’s reserves, capital structure and long-term strategic plans approved by the board.
Steps to Check IPO Allotment Status
Once the basis of allotment is finalised, you can follow these steps to check whether you received shares in the Sudeep Pharma IPO:
- Visit the official website of the IPO registrar or the stock exchange’s IPO allotment page
- Select the issue name from the dropdown: “Sudeep Pharma Limited”
- Choose one of the options – Application Number, PAN, or DP/Client ID
- Enter the required details exactly as used in the IPO application
- Submit the form to view your allotment status (Allotted / Not Allotted)
Investors applying through brokers or online platforms can also check allotment status inside their trading or demat apps once the data is updated.
Disclaimer
This article is for informational and educational purposes only. All IPO details such as price band, lot size, open and close dates, listings date and GMP are based on publicly available information as of the latest updates and may change if new announcements are made. Grey Market Premium (GMP) is unofficial and can be highly volatile. This is not a recommendation to apply or avoid. Please read the Red Herring Prospectus (RHP), consult your financial advisor and consider your risk profile before investing in the Sudeep Pharma IPO.
FAQs
Q1: What are the key terms of the Sudeep Pharma IPO?
A: The Sudeep Pharma IPO has a price band of ₹563–₹593 per share, a lot size of 25 shares, total issue size of about ₹895 crore and an IPO window from 21–25 November 2025, with listing proposed on 28 November 2025.
Q2: What is the current Sudeep Pharma IPO GMP?
A: Recent estimates suggest the sudeep pharma ipo gmp is around ₹110–₹120 per share above the upper price band, implying an expected premium of roughly 18–20%, though this can change quickly.
Q3: How can I check Sudeep Pharma IPO allotment status?
A: After the basis of allotment is finalised, visit the registrar or exchange allotment page, select Sudeep Pharma Limited, enter your PAN or application number and submit to see if shares have been allotted.
